viral envelope proteins

Summary

Summary: Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.

Top Publications

  1. ncbi Complete replication of hepatitis C virus in cell culture
    Brett D Lindenbach
    Center for the Study of Hepatitis C, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
    Science 309:623-6. 2005
  2. ncbi Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
    Thomas Pietschmann
    Department of Molecular Virology, University of Heidelberg, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany
    Proc Natl Acad Sci U S A 103:7408-13. 2006
  3. ncbi The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule
    Thomas Krey
    Institut Pasteur, CNRS URA3015, Unité de Virologie Structurale, Paris, France
    PLoS Pathog 6:e1000762. 2010
  4. ncbi Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys
    David E Clements
    Hawaii Biotech, Inc, 99 193 Aiea Heights Drive, Aiea, HI 96701, United States
    Vaccine 28:2705-15. 2010
  5. ncbi The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1
    Bimmi Shrestha
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America
    PLoS Pathog 6:e1000823. 2010
  6. ncbi Characterization of the envelope glycoproteins associated with infectious hepatitis C virus
    Gabrielle Vieyres
    Institut Pasteur de Lille, Center for Infection and Immunity of Lille, F 59019 Lille, France
    J Virol 84:10159-68. 2010
  7. ncbi Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies
    Simrat Dhillon
    MRC Virology Unit, Institute of Virology, University of Glasgow, Glasgow, United Kingdom
    J Virol 84:5494-507. 2010
  8. ncbi Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
    James E Voss
    Institut Pasteur, Departement de Virologie, Unité de Virologie Structurale, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Nature 468:709-12. 2010
  9. ncbi Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins
    Heidi E Drummer
    St Vincent s Institute of Medical Research, 41 Victoria Pde, Fitzroy, VIC 3065, Australia
    FEBS Lett 546:385-90. 2003
  10. ncbi Structure of dengue virus: implications for flavivirus organization, maturation, and fusion
    Richard J Kuhn
    Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA
    Cell 108:717-25. 2002

Detail Information

Publications189 found, 100 shown here

  1. ncbi Complete replication of hepatitis C virus in cell culture
    Brett D Lindenbach
    Center for the Study of Hepatitis C, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
    Science 309:623-6. 2005
    ..HCVcc replication was inhibited by interferon-alpha and by several HCV-specific antiviral compounds, suggesting that this in vitro system will aid in the search for improved antivirals...
  2. ncbi Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
    Thomas Pietschmann
    Department of Molecular Virology, University of Heidelberg, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany
    Proc Natl Acad Sci U S A 103:7408-13. 2006
    ..Finally, we describe an E1-specific antiserum capable of neutralizing infectivity of all HCV chimeras...
  3. ncbi The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule
    Thomas Krey
    Institut Pasteur, CNRS URA3015, Unité de Virologie Structurale, Paris, France
    PLoS Pathog 6:e1000762. 2010
    ....
  4. ncbi Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys
    David E Clements
    Hawaii Biotech, Inc, 99 193 Aiea Heights Drive, Aiea, HI 96701, United States
    Vaccine 28:2705-15. 2010
    ..These results support the development of a dengue virus tetravalent vaccine based on the four 80E subunits produced in the Drosophila S2 cell expression system...
  5. ncbi The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1
    Bimmi Shrestha
    Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America
    PLoS Pathog 6:e1000823. 2010
    ..Overall, our experiments define a complex structural epitope on DIII of DENV-1 that can be recognized by protective antibodies with therapeutic potential...
  6. ncbi Characterization of the envelope glycoproteins associated with infectious hepatitis C virus
    Gabrielle Vieyres
    Institut Pasteur de Lille, Center for Infection and Immunity of Lille, F 59019 Lille, France
    J Virol 84:10159-68. 2010
    ..Overall, our study fills a gap in the description of HCV outer morphology and should guide further investigations into virus entry and assembly...
  7. ncbi Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies
    Simrat Dhillon
    MRC Virology Unit, Institute of Virology, University of Glasgow, Glasgow, United Kingdom
    J Virol 84:5494-507. 2010
    ..The properties of all of these viruses in terms of receptor reactivity and neutralization by human antibodies were similar to JFH1(N415D), highlighting the importance of the E2 412-423 region in virus entry...
  8. ncbi Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
    James E Voss
    Institut Pasteur, Departement de Virologie, Unité de Virologie Structurale, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Nature 468:709-12. 2010
    ..3), this work also provides new insight into the acid-triggered conformational change on the virus particle and its inbuilt inhibition mechanism in the immature complex...
  9. ncbi Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins
    Heidi E Drummer
    St Vincent s Institute of Medical Research, 41 Victoria Pde, Fitzroy, VIC 3065, Australia
    FEBS Lett 546:385-90. 2003
    ..These studies suggest that functional HCV glycoproteins are not retained exclusively in the ER and transit through the secretory pathway...
  10. ncbi Structure of dengue virus: implications for flavivirus organization, maturation, and fusion
    Richard J Kuhn
    Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA
    Cell 108:717-25. 2002
    ..The structure suggests that flaviviruses, and by analogy also alphaviruses, employ a fusion mechanism in which the distal beta barrels of domain II of the glycoprotein E are inserted into the cellular membrane...
  11. ncbi Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus
    Minkyung Yi
    Center for Hepatitis Research, Institute for Human Infections and Immunity, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX 77555 1019, USA
    J Virol 81:629-38. 2007
    ..We conclude that interactions between NS2 and E1 and p7 as well as between NS2 and NS3 are essential for virus assembly and/or release and that each of these viral proteins plays an important role in this process...
  12. ncbi Binding of hepatitis C virus to CD81
    P Pileri
    IRIS, Chiron, Siena 53100, Italy
    Science 282:938-41. 1998
    ..Binding of E2 was mapped to the major extracellular loop of CD81. Recombinant molecules containing this loop bound HCV and antibodies that neutralize HCV infection in vivo inhibited virus binding to CD81 in vitro...
  13. ncbi Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
    Kartik Chandran
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Science 308:1643-5. 2005
    ..CatB and CatB/CatL inhibitors diminish the multiplication of infectious EboV-Zaire in cultured cells and may merit investigation as anti-EboV drugs...
  14. ncbi Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection
    Liliana Soroceanu
    Department of Neurosciences, California Pacific Medical Center Research Institute, Suite 220, 475 Brannan Street, San Francisco, California 94107, USA
    Nature 455:391-5. 2008
    ..Taken together, these data indicate that PDGFR-alpha is a critical receptor required for HCMV infection, and thus a target for novel anti-viral therapies...
  15. ncbi SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER
    Britta Mueller
    Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA
    J Cell Biol 175:261-70. 2006
    ..These results allow us to place SEL1L in the broader context of glycoprotein degradation, and imply the existence of multiple independent modes of extraction of misfolded substrates from the mammalian ER...
  16. ncbi Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
    Y Chen
    Department of Internal Medicine, University of Michigan, Ann Arbor 48109, USA
    Nat Med 3:866-71. 1997
    ..Similar motifs were also identified in the envelope proteins of other flaviviridae. Developing pharmaceuticals that inhibit target cell binding may be an effective strategy for treating flavivirus infections...
  17. ncbi West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection
    Carl W Davis
    Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Virol 80:1290-301. 2006
    ..We believe this is the first report of a pathogen interacting more efficiently with DC-SIGNR than with DC-SIGN. Our results should lead to the discovery of new mechanisms by which these well-studied lectins discriminate among ligands...
  18. ncbi Vaccine prevention of maternal cytomegalovirus infection
    Robert F Pass
    Department of Pediatrics, University of Alabama at Birmingham, Birmingham 35233, USA
    N Engl J Med 360:1191-9. 2009
    ..Congenital infection with cytomegalovirus (CMV) is an important cause of hearing, cognitive, and motor impairments in newborns...
  19. ncbi Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus
    Daniel X Johansson
    Department of Medicine, Center for Molecular Medicine, Karolinska University Hospital Solna, Karolinska Institutet, 171 76 Stockholm, Sweden
    Proc Natl Acad Sci U S A 104:16269-74. 2007
    ....
  20. ncbi Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity
    Zhen-Yong Keck
    Department of Pathology, Stanford University School of Medicine, CA 94305, USA
    J Virol 78:7257-63. 2004
    ..Finally, H-111 blocks HCV-like particle binding to and HCV virion infection of target cells, suggesting the involvement of this epitope in virus binding and entry...
  21. ncbi Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding
    Kathleen McCaffrey
    Macfarlane Burnet Institute for Medical Research and Public Health, 85 Commercial Rd, Melbourne, Australia
    J Virol 81:9584-90. 2007
    ..Our data provide insights into the E2 structure by suggesting that the three variable regions reside outside a conserved E2 core...
  22. ncbi In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes
    Birke Bartosch
    , , IFR 128, , , 69364 Lyon Cedex 07, France
    Proc Natl Acad Sci U S A 100:14199-204. 2003
    ..The ability to assay neutralizing anti-HCV should permit an assessment of the prospects for successful Ab-mediated passive and active immunoprophylaxis against hepatitis C...
  23. ncbi Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
    Birke Bartosch
    Laboratoire de Vectorologie Rétrovirale et Thérapie Génique, Institut National de la Santé et de la Recherche Médicale U412, IFR 128, Ecole Normale Superieure de Lyon, 69364 Lyon Cedex 07, France
    J Exp Med 197:633-42. 2003
    ..Altogether, these studies indicate that these pseudo-particles may mimic the early infection steps of parental HCV and will be suitable for the development of much needed new antiviral therapies...
  24. ncbi Cellular and viral requirements for rapid endocytic entry of herpes simplex virus
    Anthony V Nicola
    Medical Virology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892 1888, USA
    J Virol 78:7508-17. 2004
    ..Thus, similar to entry via direct penetration at the cell surface, HSV entry into cells by wortmannin-sensitive endocytosis is efficient, involves rapid cellular uptake of viral particles, and requires gB, gD, and gH-gL...
  25. ncbi Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus
    Jean Christophe Meunier
    Molecular Hepatitis Section, LID, NIAID, NIH, Bldg 50, Rm 6537, 50 South Dr, MSC 8009, Bethesda, MD 20892 8009, USA
    J Virol 82:966-73. 2008
    ..In addition, robust neutralization was also observed against cell culture-adapted viruses of genotypes 1a and 2a. Results from this study suggest that these MAbs may have the potential to prevent HCV infection...
  26. ncbi Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB
    Doina Atanasiu
    Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Virol 84:12292-9. 2010
    ..The third step may be common to other herpesviruses...
  27. ncbi Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
    Ania Owsianka
    MRC Virology Unit, Institute of Virology, University of Glasgow, UK
    J Virol 79:11095-104. 2005
    ..Thus, identification of a broadly neutralizing antibody that recognizes a linear epitope is likely to be of significant benefit to future vaccine and therapeutic antibody development...
  28. ncbi The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein
    François Helle
    Institut de Biologie de Lille UMR8161, CNRS, Université Lille I and II and Institut Pasteur de Lille, Lille, France
    J Virol 81:8101-11. 2007
    ..In conclusion, this work indicates that HCV glycans contribute to the evasion of HCV from the humoral immune response...
  29. ncbi Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1
    Miri Yoon
    Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    J Virol 77:9221-31. 2003
    ..The sequence of the N terminus determines whether nectin-2 or 3-O-sulfated heparan sulfate, as well as HVEM, can serve as entry/fusion receptors...
  30. ncbi Identification of new functional regions in hepatitis C virus envelope glycoprotein E2
    Anna Albecka
    Institut Pasteur de Lille, Center for Infection and Immunity of Lille, F 59019 Lille, France
    J Virol 85:1777-92. 2011
    ..In conclusion, our study highlights new functional and structural regions in HCV envelope glycoprotein E2...
  31. ncbi In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
    Meital Gal-Tanamy
    Center for Hepatitis Research, Institute for Human Infections and Immunity, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555 1073, USA
    Proc Natl Acad Sci U S A 105:19450-5. 2008
    ....
  32. ncbi Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity
    Pei Zhang
    Division of Hematology and Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 106:7537-41. 2009
    ..Our studies contribute to understanding the mechanisms of antibody-mediated neutralization and interference and provide a practical approach to the development of more potent and broadly reactive hepatitis C immune globulins...
  33. ncbi Phylogenetic comparison of the carboxy-terminal region of glycoprotein C (gC) of bovine herpesviruses (BoHV) 1.1, 1.2 and 5 from South America (SA)
    P A Esteves
    Embrapa Suinos e Aves, BR 153, Km 110, CEP 89700 000, Concordia, SC, Brazil
    Virus Res 131:16-22. 2008
    ..1, BoHV-1.2 and BoHV-5 after phylogenetic analysis. The results suggest that the phylogenetic analysis performed here can be used as a potential molecular epidemiological tool for herpesviruses...
  34. ncbi Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress
    Marisa K Isaacson
    McArdle Laboratory for Cancer Research, University of Wisconsin Madison Medical School, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
    J Virol 83:3891-903. 2009
    ..Taken together, our results indicate that gB is required for virus entry and cell-to-cell spread of the virus. However, HCMV gB is not absolutely required for virus attachment or assembly and egress from infected cells...
  35. ncbi Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein
    Mario Perotti
    Laboratorio di Microbiologia e Virologia, Universita Vita Salute San Raffaele, DIBIT2, Via Olgettina 60, 20132 Milano, Italia
    J Virol 82:1047-52. 2008
    ..Fab e137 was also able to inhibit cell culture-grown HCV (genotype 2a). These data indicate that broadly cross-reacting and cross-neutralizing antibodies are generated during HCV infection...
  36. ncbi Domain III of the envelope protein as a dengue vaccine target
    Maria G Guzman
    Department of Virology, PAHO WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kouri Tropical Medicine Institute, Autopista Novia del Mediodia, Km 6, Apdo 601, Marianao 13, Havana, Cuba
    Expert Rev Vaccines 9:137-47. 2010
    ..Due to the results obtained concerning the immune response and protection in mice and monkeys, particular attention is paid to the chimeric protein domain III fused to p64k of Neisseria meningitidis...
  37. ncbi Chikungunya virus of Asian and Central/East African genotypes in Malaysia
    I Ching Sam
    Tropical Infectious Diseases Research and Education Centre, Department of Medical Microbiology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia
    J Clin Virol 46:180-3. 2009
    ..In Malaysia, limited CHIKV outbreaks of the endemic Asian and imported Central/East African genotypes were reported in 1998 and 2006. Since April 2008, an unprecedented nationwide outbreak has affected Malaysia...
  38. ncbi A structural perspective of the flavivirus life cycle
    Suchetana Mukhopadhyay
    Department of Biological Sciences, Purdue University, 915 West State Street, West Lafayette, Indiana 47907 2054, USA
    Nat Rev Microbiol 3:13-22. 2005
    ..This review focuses mainly on structural studies of dengue virus...
  39. ncbi Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
    Dai Wang
    Department of Molecular Biology, Princeton University, NJ 08544, USA
    Proc Natl Acad Sci U S A 102:18153-8. 2005
    ....
  40. ncbi Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein
    Simona Ozden
    Unité d Epidémiologie et Physiopathologie des Virus Oncogènes, CNRS URA 3015, Institut Pasteur, 75724 Paris, France
    J Biol Chem 283:21899-908. 2008
    ..Our results demonstrate the role of furin-like proteases in the processing of CHIKV particles and point out new approaches to inhibit this infection...
  41. ncbi Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization
    Steevenson Nelson
    Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS Pathog 4:e1000060. 2008
    ..Thus, in addition to a role in facilitating viral entry, changes in E protein arrangement associated with maturation modulate neutralization sensitivity and introduce an additional layer of complexity into humoral immunity against WNV...
  42. ncbi Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus
    Teresa J Broering
    MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts 02130, USA
    J Virol 83:12473-82. 2009
    ....
  43. ncbi Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver
    Søren U Nielsen
    School of Clinical Medical Sciences, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK
    J Gen Virol 85:1497-507. 2004
    ..Glycoprotein E2 was 62 kDa before and 36 kDa after deglycosylation, but E2-P7 was not detected. This was in contrast to recombinant sources of E2 which contain E2-P7...
  44. ncbi Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
    Mayla Hsu
    Aaron Diamond AIDS Research Center and Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
    Proc Natl Acad Sci U S A 100:7271-6. 2003
    ..However, HIV-HCV pseudotype infectivity was inhibited by a recombinant soluble form of CD81 and a mAb specific for CD81, suggesting that CD81 may be a component of a receptor complex...
  45. ncbi Genetic diversity and evolution of hepatitis C virus--15 years on
    Peter Simmonds
    Centre for Infectious Diseases, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, UK
    J Gen Virol 85:3173-88. 2004
    ..These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses...
  46. ncbi RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells
    Min Liu
    Department of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University, Shanghai, China
    Biosci Biotechnol Biochem 70:2049-55. 2006
    ..This may provide an approach for the development of novel prophylactic or therapeutic agents for HCV infection...
  47. ncbi Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody
    W M P B Wahala
    Department of Microbiology and Immunology, CB 7290 University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA
    Virology 392:103-13. 2009
    ..Our results have implications for understanding protective immunity following natural DENV infection and for evaluating DENV vaccines...
  48. ncbi Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody
    Mickaël V Cherrier
    Department of Biological Sciences, Purdue University, West Lafayette, IN 47907 2054, USA
    EMBO J 28:3269-76. 2009
    ..As these highly cross-reactive antibodies are often weakly neutralizing they also may contribute to antibody-dependent enhancement and flavi virus pathogenesis thereby complicating development of safe and effective vaccines...
  49. ncbi Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D
    M Lopez
    Institute of Cancerology and Immunology, INSERM U119, Marseille, France
    J Virol 74:1267-74. 2000
    ..Binding of wt HSV-1 gD to soluble nectin2 was not detectable. (iv) A major region of nectin2 functional in virus entry mapped to the V domain, located at the N terminus...
  50. ncbi Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry
    Miriam Triyatni
    Liver Diseases Section, National Institute of Diabetes and DigestiveKidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Virol 76:9335-44. 2002
    ..Altogether, our results indicate that HCV-LPs can be used to further characterize the mechanisms involved in the early steps of HCV infection...
  51. ncbi Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1
    Richard S B Milne
    Department of Microbiology, University of Pennsylvania, School of Dental Medicine, 215 Levy Building, 240 South 40th Street, Philadelphia, PA 19104 6002, USA
    J Virol 79:6655-63. 2005
    ..Resistance to similar reagents should therefore not be taken as proof of HSV entry by a nonendosomal pathway. These data define a novel gD receptor-dependent acid-independent endocytic entry pathway for HSV...
  52. ncbi Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants
    E Helseth
    Dana Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts
    J Virol 64:2416-20. 1990
    ..Furthermore, virus transmission appears to be less sensitive to inhibition of membrane fusion than is syncytium formation...
  53. ncbi A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity
    D Lindemann
    Institut fur Virologie und Immunbiologie, Universitat Wurzburg, Versbacher Str 7, 97078 Wurzburg, 01307 Dresden, Germany
    J Virol 75:5762-71. 2001
    ..While the SP N terminus was found to mediate the specificity of FV Env to interact with FV capsids, it was dispensable for Env targeting to the secretory pathway and FV envelope-mediated infectivity of murine leukemia virus pseudotypes...
  54. ncbi Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins
    J Overbaugh
    Division of Human Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave, Seattle, WA 98109 1024, USA
    Microbiol Mol Biol Rev 65:371-89, table of contents. 2001
    ..In this review, we will focus on the various strategies used by mammalian retroviruses to gain entry into the cell. The choice of receptors will also be discussed in light of pressures that drive viral evolution and persistence...
  55. ncbi A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection
    Theodore C Pierson
    Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Virology 346:53-65. 2006
    ..WNV RVPs are capable of only a single round of infection, can be used under BSL-2 conditions, and offer a rapid and quantitative approach for detecting virus entry and its inhibition by neutralizing antibody...
  56. ncbi Folding of hepatitis C virus E1 glycoprotein in a cell-free system
    M Merola
    IRIS Research Center, Chiron, 53100 Siena, Italy
    J Virol 75:11205-17. 2001
    ..The folding of viral proteins can thus depend on complex interactions between neighboring proteins within the polyprotein precursor...
  57. ncbi Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53
    R M Kinney
    Division of Vector Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA
    Virology 230:300-8. 1997
    ..Although the NS3-250-Val mutation clearly affected virus replication in vitro, it was not a major determinant of attenuation for PDK-53 virus in suckling mice...
  58. ncbi Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread
    D C Johnson
    Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, Oregon 97201, USA
    J Virol 75:821-33. 2001
    ..Delivery of virus particles to cell junctions would be expected to enhance virus spread and enable viruses to avoid host immune defenses...
  59. ncbi Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia
    Y Yao
    Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
    Genes Brain Behav 7:103-12. 2008
    ..05) in the patients compared with the controls. Thus, studies aiming to further understanding of complex human disease such as schizophrenia may need to be extended beyond the strictly protein-coding fraction of the transcriptome...
  60. ncbi Optimized large-scale production of high titer lentivirus vector pseudotypes
    Miguel Sena-Esteves
    Department of Surgery, The Children s Hospital of Philadelphia, Abramson Research Center, 3615 Civic Center Blvd, Philadelphia, PA 19104, USA
    J Virol Methods 122:131-9. 2004
    ..The best conditions for each individual pseudotype yielded lentivirus vector stocks with titers above 1 x 10(9) tu/mL for most pseudotypes, and higher than 1 x 10(10) tu/mL for VSV-G...
  61. ncbi A membrane protein required for dislocation of misfolded proteins from the ER
    Brendan N Lilley
    Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA
    Nature 429:834-40. 2004
    ..We conclude that Derlin-1 is an important factor for the extraction of certain aberrantly folded proteins from the mammalian ER...
  62. ncbi Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate
    P E Pertel
    Department of Medicine, Northwestern University Medical School, Chicago, Illinois, 60611, USA
    Virology 279:313-24. 2001
    ..Overall, the viral and cellular determinants of HSV-1-induced cell fusion are similar to those for viral entry, except that HSV-1 entry is significantly enhanced by binding of virus to cell surface heparan sulfate...
  63. ncbi A human neutralizing antibody against a conformational epitope shared by oligomeric SARS S1 protein
    Jinzhu Duan
    National Laboratory of Biomacromolecules, and Centre for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing
    Antivir Ther 11:117-23. 2006
    ..This study should aid in the manufacture of neutralizing antibody, provide a better understanding the immunological characteristics of SARS protein and facilitate the design of a SARS vaccine...
  64. ncbi Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus
    Kuo-Ming Lip
    Institute of Molecular and Cell Biology, Proteos, 61 Biopolis Drive, Singapore 138673
    J Virol 80:941-50. 2006
    ..These results provide evidence of novel neutralizing epitopes that are located in the HR2 domain and the spacer region immediately upstream of the HR2 of the S protein...
  65. ncbi Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry
    Rene Broer
    Department of Medical Microbiology, E4 P, Leiden University Medical Center, P O Box 9600, 2300 RC Leiden, The Netherlands
    J Virol 80:1302-10. 2006
    ..Examination of the oligomeric state of the chimeric S proteins in SARSpp revealed that S(VSV-TMDCyt) trimers were less stable than wild-type S trimers, possibly explaining the lowered fusogenicity and infectivity...
  66. ncbi A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway
    A Bonavia
    Retrovirus Biology Laboratory, Department of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Virology 341:12-23. 2005
    ..Our data suggest that the envelope from the neurovirulent SIV/17E-Fr interacts with CCR5 in a CD4-independent manner, and changes in the TM protein of this virus are important components that contribute to neurovirulence in SIV...
  67. ncbi Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
    Fang Li
    Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Laboratory of Molecular Medicine, 320 Longwood Avenue, Boston, MA 02115, USA
    Science 309:1864-8. 2005
    ..The structure of the RBD suggests ways to make truncated disulfide-stabilized RBD variants for use in the design of coronavirus vaccines...
  68. ncbi Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4
    Cheryl Pikora
    New England Primate Research Center, Harvard Medical School, One Pine Hill Drive, Southborough, MA 01722, USA
    J Virol 79:12575-83. 2005
    ..Thus, glycans at positions 3 and 11 of SIV239 gp120 may be particularly important for shielding the CD4-binding site from antibody recognition...
  69. ncbi Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain
    Christopher E Yi
    Aaron Diamond AIDS Research Center, The Rockefeller University, 455 1st Avenue, 7th Floor, New York, NY 10016, USA
    J Virol 79:11638-46. 2005
    ..Our data have implications for the rational design of vaccine and antiviral agents as well as for understanding viral tropism...
  70. ncbi Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats
    Ran-Yi Liu
    State Key Laboratory for Oncology in South China, Cancer Center, Sun Yat-sen University, 651 Dong-Feng Road East, Guangzhou 510060, China
    Virus Res 112:24-31. 2005
    ....
  71. ncbi Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses
    J D Trujillo
    Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164 7040, USA
    J Virol 78:9190-202. 2004
    ..Thus, the glycosylation of linear immunodominant nonneutralization epitopes, but not epitope deletion, is an effective strategy to enhance neutralizing antibody responses by immunization...
  72. ncbi Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus
    Katharine N Bossart
    Department of Microbiology and Immunology, F Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814 4799, USA
    J Virol 79:6690-702. 2005
    ..This HeV sG glycoprotein will be exceedingly useful for structural studies, receptor identification strategies, and vaccine development goals for these important emerging viral agents...
  73. ncbi Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice
    Jong-Soo Lee
    BioLeaders corporation, Daejeon, Korea
    J Virol 80:4079-87. 2006
    ..These results indicate that mucosal immunization with recombinant L. casei expressing SARS-associated coronavirus S protein on its surface provides an effective means for eliciting protective immune response against the virus...
  74. ncbi Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus
    Liurong Fang
    Laboratory of Animal Virology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, Hubei, P.R.China
    Virus Genes 32:5-11. 2006
    ..These results indicate that the high immunogenicity of the modified GP5 might facilitate the development of improved PRRS vaccines in the future...
  75. ncbi Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species
    Meng Yu
    CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria, Australia
    J Immunol Methods 331:1-12. 2008
    ..Considering that a large number of animal species are known to be susceptible to SARS-CoV, these assays will be a useful tool to trace the origin and transmission of SARS-CoV and to minimise the risk of animal-to-human transmission...
  76. ncbi Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
    Kumari G Lokugamage
    Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, United States
    Vaccine 26:797-808. 2008
    ..Our results show that chimeric VLP can be an effective vaccine strategy against SCoV infection...
  77. ncbi Chicken single-chain variable fragments against the SARS-CoV spike protein
    Yu Ching Lee
    Graduate Institute of Pharmaceutical Science, Taipei Medical University, Taipei, Taiwan
    J Virol Methods 146:104-11. 2007
    ..In conclusion, the results suggest that the chicken scFv phage display system can be a potential model for mass production of high-affinity antibodies against the SARS-CoV spike protein...
  78. ncbi Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model
    Zhaochun Chen
    Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, 50 South Drive, MSC 8009, Bethesda, MD 20892, USA
    J Virol 81:8989-95. 2007
    ....
  79. ncbi The use of hepatitis C virus NS3/4A and secreted alkaline phosphatase to quantitate cell-cell membrane fusion mediated by severe acute respiratory syndrome coronavirus S protein and the receptor angiotensin-converting enzyme 2
    Chih Fong Chou
    Institute of Molecular and Cell Biology, Proteos, Singapore 138673
    Anal Biochem 366:190-6. 2007
    ..In this study, we developed a simple, sensitive, and quantitative assay to study the membrane fusion process by measuring the extracellular activity of SEAP...
  80. ncbi A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge
    Manisha Saini
    National Institute of Immunology, New Delhi 110-067, India
    J Virol 77:3487-94. 2003
    ..Importantly, these antibodies were obtained without the use of an adjuvant. The immunized mice showed significant protection against a lethal JEV challenge...
  81. ncbi Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS
    Benoit Callendret
    Unite de Genetique Moleculaire des Virus Respiratoires, URA CNRS 1966, EA 302 Université Paris 7, France
    Virology 363:288-302. 2007
    ..Our observations are likely to be useful for the construction of plasmid and viral vectors designed for optimal expression of intronless genes derived from cytoplasmic RNA viruses...
  82. ncbi Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies
    Seraphin Kuate
    Department of Molecular and Medical Virology, Ruhr University Bochum, D 44780 Bochum, Germany
    Virology 362:26-37. 2007
    ..Both approaches were effective in a SARS-S-expressing tumor challenge model and thus warrant further investigation...
  83. ncbi A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus
    Jincun Zhao
    Department of Immunology, Peking University Health Science Center, Peking University, 38 Xueyuan Road, Beijing 100083, China
    Virology 359:362-70. 2007
    ..Our data suggest a possibility that, although the beta6 strand alone is able to bind with ACE2 with relatively high affinity, residues outside the S-RBM could also assist the receptor binding of SARS-CoV-S protein...
  84. ncbi Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice
    Barry Rockx
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27699 7435, USA
    J Virol 81:7410-23. 2007
    ....
  85. ncbi Immunization of mice with a DNA vaccine based on severe acute respiratory syndrome coronavirus spike protein fragment 1
    Bo Zhao
    Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, Jilin University [corrected] Changchun, China
    Viral Immunol 19:518-24. 2006
    ..These results are promising for the protective immunization of humans...
  86. ncbi Development of an effective Japanese encephalitis virus-specific DNA vaccine
    Chang Jer Wu
    Department of Food Science, National Taiwan Ocean University, 2, Pei Ning Road, Keelung 202, Taiwan
    Microbes Infect 8:2578-86. 2006
    ..Consequently, the efficacy of the newly developed DNA vaccines was validated. This should pave the way to clinical trials in man...
  87. ncbi Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges
    Danher Wang
    Division of Bio defense Vaccines, GenPhar Inc, 871 Lowcountry Blvd, Mount Pleasant, SC 29464, USA
    Virology 353:324-32. 2006
    ..Therefore, the cAdVaxM(fus) vaccine serves as a promising vaccine candidate to prevent and contain multi-strain infections by MARV...
  88. ncbi Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants
    Jan Ter Meulen
    Crucell Holland B V, Leiden, Netherlands
    PLoS Med 3:e237. 2006
    ..Combinations of virus-neutralizing, noncompeting mAbs may have these properties...
  89. ncbi Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus
    Brian Tripet
    Department of Biochemistry and Molecular Genetics, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045, USA
    J Struct Biol 155:176-94. 2006
    ....
  90. ncbi Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse
    Melissa Coughlin
    Department of Microbiology and Immunology MC790 College of Medicine, University of Illinois at Chicago, Room E705 835 S Wolcott AveChicago, IL 60612, USA
    Virology 361:93-102. 2007
    ..Unique human mAbs could be used as a cocktail that would simultaneously target several neutralizing epitopes and prevent emergence of escape mutants...
  91. ncbi SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity
    Mi-fang Liang
    State Key Laboratory for Infectious Disease Control and Prevention, Institute for Viral Disease Control and Prevention, Beijing 100052, China
    Biomed Environ Sci 18:363-74. 2005
    ..The neutralizing antibodies we generated in this study may be more promising candidates for prophylaxis and treatment of SARS infection...
  92. ncbi Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus
    Timothy Sheahan
    Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina 27699 7435, USA
    J Virol 82:8721-32. 2008
    ..Furthermore, zoonotic SARS-CoV was variably neutralized by antibodies that were effective against the epidemic strain, highlighting their utility for evaluating passive immunization efficacy...
  93. ncbi Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity
    N Chazal
    Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia 22908, USA
    J Virol 75:4014-8. 2001
    We have investigated the effects of Nef on infectivity in the context of various viral envelope proteins. These experiments were performed with a minimal vector system where Nef is the only accessory protein present...
  94. ncbi Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China
    Y Guan
    Department of Microbiology, The University of Hong Kong, University Pathology Building, Queen Mary Hospital, Hong Kong Special Administrative Region, People s Republic of China
    Science 302:276-8. 2003
    ..The detection of SCoV-like viruses in small, live wild mammals in a retail market indicates a route of interspecies transmission, although the natural reservoir is not known...
  95. ncbi Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein
    Tin-Yun Ho
    Institute of Chinese Medical Science, China Medical University, ROC, Taichung, Taiwan
    Biochem Biophys Res Commun 313:938-47. 2004
    ..Taken together, these results suggested that recombinant S protein exhibited the antigenicity and receptor-binding ability, and it could be a good candidate for further developing SARS vaccine and anti-SARS therapy...
  96. ncbi S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients
    Heike Hofmann
    Institute for Clinical and Molecular Virology, , Nikolaus-Fiebiger-Center, , D-91054 Erlangen, Germany
    J Virol 78:6134-42. 2004
    ..Moreover, we provide evidence that SARS-CoV infection might not be limited to lung tissue and can be inhibited by the humoral immune response in infected patients...
  97. ncbi Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA
    Li-Rung Huang
    Graduate Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan
    J Med Virol 73:338-46. 2004
    ..Antibodies against SARS-CoV N protein appear at the early stage of infection, therefore, N protein-based ELISA could serve as a simple, sensitive, and specific test for diagnosing SARS-CoV infection...
  98. ncbi Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies
    Hong Zhang
    Department of Cell Biology and Genetics, College of Life Sciences, Peking University, Beijing 100871, China
    J Virol 78:6938-45. 2004
    ..Identification of a conserved antigenic determinant on the S2 domain of the SARS-CoV S protein, which has the potential for inducing neutralizing antibodies, has implications in the development of effective vaccines against SARS-CoV...
  99. ncbi An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies
    Tong Zhou
    Department of Medicine, University of Alabama at Birmingham, 35294, USA
    J Virol 78:7217-26. 2004
    ..Thus, this region of the spike protein might be a target for generation of therapeutic neutralizing antibodies against SARS CoV and for vaccine development to elicit protective humoral immunity...
  100. ncbi Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
    Ursula J Buchholz
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 8007, USA
    Proc Natl Acad Sci U S A 101:9804-9. 2004
    ....
  101. ncbi Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
    Jody D Berry
    National Centre for Foreign Animal Disease, CFIA, Winnipeg, Canada
    J Virol Methods 120:87-96. 2004
    ..These studies highlight the importance of using standardised assays and reagents. These mAbs will be useful for the development of diagnostic tests, studies of SARS-CoV pathogenesis and vaccine development...

Research Grants69

  1. Dengue Epitope Vaccine,Tetravalent & MHCII-Targeted
    J Thomas August; Fiscal Year: 2007
    ..technologies will be applied with both mouse and human antisera to identify the minimum sequences of the viral envelope proteins effective as neutralizing antibody epitopes...
  2. Protein interactions by analytical ultracentrifugation
    PETER GETTINS; Fiscal Year: 2007
    ..Systems that will be studied include (i) viral envelope proteins gp41 and gp120 from HIV and the S1 and S2 from SARS coronavirus (Caffrey), (ii) interactions of the LDL ..
  3. MUTATIONAL AND PHYSICAL ANALYSIS OF THE MULV-E RECEPTOR
    Lorraine Albritton; Fiscal Year: 2001
    ..Interactions of the viral envelope proteins have been implicated as directly causative or as accelerating factors in viral pathogenesis...
  4. Virion Sialic Acid and HSV Ocular Infection
    Curtis R Brandt; Fiscal Year: 2010
    ..TAT-C, that inhibits HSV-1 infection and preliminary data suggests TAT-C binds to sialic acids on viral envelope proteins. A second critical finding recently published, is that sialic acids on one or more HSV-1 entry proteins ..
  5. Novel HIV Neutralizing Human MAbs from Transgenic Mice
    Abraham Pinter; Fiscal Year: 2006
    ..This latter antigen was uccessful in eliciting Mabs that recognized native viral envelope proteins, including antibodies with potent neutralizing activities for the SF162 strain...
  6. Replication and Persistence of Primate Lentiviruses
    Welkin Johnson; Fiscal Year: 2007
    ..neutralization, either by SIV-positive animal plasma or by monoclonal antibodies directed against the viral envelope proteins, a property it also shares with clinically relevant, primary isolates of HIV- 1...
  7. Replication and Persistence of Primate Lentiviruses
    Welkin Johnson; Fiscal Year: 2009
    ..neutralization, either by SIV-positive animal plasma or by monoclonal antibodies directed against the viral envelope proteins, a property it also shares with clinically relevant, primary isolates of HIV- 1...
  8. Molecular Mechanism of Sec1p-Regulated Membrane Fusion
    CHAVELA CARR; Fiscal Year: 2006
    ..cellular proteins, called SNAREs, share structural similarity with the fusion-active conformation of the viral envelope proteins. Despite the inherent ability of SNARE proteins to fuse membranes, eukaryotic cells require at least a ..
  9. Molecular Mechanism of Sec1p-Regulated Membrane Fusion
    CHAVELA CARR; Fiscal Year: 2002
    ..cellular proteins, called SNAREs, share structural similarity with the fusion-active conformation of the viral envelope proteins. Despite the inherent ability of SNARE proteins to fuse membranes, eukaryotic cells require at least a ..
  10. Molecular Mechanism of Sec1p-Regulated Membrane Fusion
    CHAVELA CARR; Fiscal Year: 2007
    ..cellular proteins, called SNAREs, share structural similarity with the fusion-active conformation of the viral envelope proteins. Despite the inherent ability of SNARE proteins to fuse membranes, eukaryotic cells require at least a ..
  11. Contributions of Antibody to Control of SIV infection
    Welkin Johnson; Fiscal Year: 2003
    ..neutralization, either by SIV-positive animal plasma or monoclonal antibodies directed against the viral envelope proteins, a property it shares with clinically relevant, primary isolates of HIV-1...
  12. REGULATION OF HIV ENV FUNCTION DURING VIRION MATURATION
    Christopher Aiken; Fiscal Year: 2002
    ..constraints on the gp41 cytoplasmic domain are revealed, unlocking the fusogenic activity of the viral envelope proteins. Experiments will be performed to test this model...
  13. Role of Phospholipid Scramblase in Interferon Action
    Robert Silverman; Fiscal Year: 2005
    ..The possibility that PLSCR1 co-localizes with viral envelope proteins in detergent-resistant membrane "rafts" will be explored, and the functional significance of conserved ..
  14. Cell Therapy by In Vivo Fusion
    Markus Grompe; Fiscal Year: 2007
    ..Aim 3 is geared toward enhancing the efficiency of in vivo fusion and thereby increasing the number of bone marrow derived hepatocytes. Fusogenic viral envelope proteins will be used to artificially induce cell fusion.
  15. Mitochondrial fusion: analysis of Fzo function
    David Chan; Fiscal Year: 2005
    ..Intriguingly, Fzo contains several coiled-coil motifs, reminiscent of viral envelope proteins and SNARE complexes that are directly involved in other types of membrane fusion...
  16. HIV-1 Resistance to Chemokine Receptor Antagonists
    Daniel Kuritzkes; Fiscal Year: 2007
    Entry of HIV-1 into target cells involves the interaction of viral envelope proteins with specific cell surface receptors, leading ultimately to fusion of viral and host cell membranes...
  17. Biochemical and NMR Studies of Influenza HA2
    Michael Caffrey; Fiscal Year: 2007
    The viral envelope proteins HA1 and HA2 play critical roles in influenza entry. HA2 mediates fusion of the viral and cellular membranes, thereby allowing entry of the influenza genetic material...
  18. gp120 covalent analogs as candidate HIV vaccines
    Sudhir Paul; Fiscal Year: 2007
    ..Such Abs are made only rarely in infected individuals or following immunization with viral envelope proteins because of various immune evasion mechanisms deployed by HIV...